620 related articles for article (PubMed ID: 11012914)
21. The effects of parathyroid hormone, alendronate, or both in men with osteoporosis.
Finkelstein JS; Hayes A; Hunzelman JL; Wyland JJ; Lee H; Neer RM
N Engl J Med; 2003 Sep; 349(13):1216-26. PubMed ID: 14500805
[TBL] [Abstract][Full Text] [Related]
22. Bone mineral disorders in pediatric and adolescent renal transplant recipients.
Derakhshan A; Behbahan AG; Lotfi M; Omrani GH; Fallahzadeh MH; Basiratnia M; Al-Hashemi GH
Pediatr Transplant; 2011 Jun; 15(4):367-75. PubMed ID: 21429060
[TBL] [Abstract][Full Text] [Related]
23. Evidence for preservation of cortical bone mineral density in patients on continuous ambulatory peritoneal dialysis.
Mottet JJ; Horber FF; Casez JP; Descoeudres C; Jaeger P
J Bone Miner Res; 1996 Jan; 11(1):96-104. PubMed ID: 8770702
[TBL] [Abstract][Full Text] [Related]
24. Prolactinomas in adolescents: persistent bone loss after 2 years of prolactin normalization.
Colao A; Di Somma C; Loche S; Di Sarno A; Klain M; Pivonello R; Pietrosante M; Salvatore M; Lombardi G
Clin Endocrinol (Oxf); 2000 Mar; 52(3):319-27. PubMed ID: 10718830
[TBL] [Abstract][Full Text] [Related]
25. Increase in bone mineral density of patients with rheumatoid arthritis treated with anti-TNF-alpha antibody: a prospective open-label pilot study.
Lange U; Teichmann J; Müller-Ladner U; Strunk J
Rheumatology (Oxford); 2005 Dec; 44(12):1546-8. PubMed ID: 16263785
[TBL] [Abstract][Full Text] [Related]
26. Postmenopausal Canarian women receiving oral glucocorticoids have an increased prevalence of vertebral fractures and low values of bone mineral density measured by quantitative computer tomography and dual X-ray absorptiometry, without significant changes in parathyroid hormone.
Sosa M; Jódar E; Saavedra P; Navarro MC; Gómez de Tejada MJ; Martín A; Peña P; Gómez J
Eur J Intern Med; 2008 Jan; 19(1):51-6. PubMed ID: 18206602
[TBL] [Abstract][Full Text] [Related]
27. [Bone density and laboratory parameters of bone metabolism in patients with terminal heart disease].
Christ E; Linka A; Junga G; Odermatt M; Steinert H; Kiowski W; Schmid C
Schweiz Med Wochenschr; 1996 Sep; 126(37):1553-9. PubMed ID: 8927958
[TBL] [Abstract][Full Text] [Related]
28. Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease.
Bjøro K; Brandsaeter B; Wiencke K; Bjøro T; Godang K; Bollerslev J; Schrumpf E
Scand J Gastroenterol; 2003 Mar; 38(3):320-7. PubMed ID: 12737449
[TBL] [Abstract][Full Text] [Related]
29. Femoral neck osteopenia in patients with inflammatory bowel disease.
Pollak RD; Karmeli F; Eliakim R; Ackerman Z; Tabb K; Rachmilewitz D
Am J Gastroenterol; 1998 Sep; 93(9):1483-90. PubMed ID: 9732930
[TBL] [Abstract][Full Text] [Related]
30. Cyclosporine induces high bone turnover and may contribute to bone loss after heart transplantation.
Thiébaud D; Krieg MA; Gillard-Berguer D; Jacquet AF; Goy JJ; Burckhardt P
Eur J Clin Invest; 1996 Jul; 26(7):549-55. PubMed ID: 8864416
[TBL] [Abstract][Full Text] [Related]
31. Bone Disease and Serum Fibroblast Growth Factor-23 Levels in Renal Transplant Recipients.
Coskun Y; Paydas S; Balal M; Soyupak S; Kara E
Transplant Proc; 2016; 48(6):2040-5. PubMed ID: 27569941
[TBL] [Abstract][Full Text] [Related]
32. Bone loss after renal transplantation: role of hyperparathyroidism, acidosis, cyclosporine and systemic disease.
Heaf J; Tvedegaard E; Kanstrup IL; Fogh-Andersen N
Clin Transplant; 2000 Oct; 14(5):457-63. PubMed ID: 11048990
[TBL] [Abstract][Full Text] [Related]
33. Allogeneic bone marrow transplantation is associated with a preferential femoral neck bone loss.
Buchs N; Helg C; Collao C; Chapuis B; Slosman D; Bonjour JP; Rizzoli R
Osteoporos Int; 2001; 12(10):880-6. PubMed ID: 11716193
[TBL] [Abstract][Full Text] [Related]
34. Bone mass continues to increase at the hip after parathyroid hormone treatment is discontinued in glucocorticoid-induced osteoporosis: results of a randomized controlled clinical trial.
Lane NE; Sanchez S; Modin GW; Genant HK; Pierini E; Arnaud CD
J Bone Miner Res; 2000 May; 15(5):944-51. PubMed ID: 10804025
[TBL] [Abstract][Full Text] [Related]
35. Bone loss and turnover after cardiac transplantation.
Shane E; Rivas M; McMahon DJ; Staron RB; Silverberg SJ; Seibel MJ; Mancini D; Michler RE; Aaronson K; Addesso V; Lo SH
J Clin Endocrinol Metab; 1997 May; 82(5):1497-506. PubMed ID: 9141540
[TBL] [Abstract][Full Text] [Related]
36. Bone mass and mineral metabolism in liver transplant patients treated with FK506 or cyclosporine A.
Monegal A; Navasa M; Guañabens N; Peris P; Pons F; Martínez de Osaba MJ; Rimola A; Rodés J; Muñoz-Gómez J
Calcif Tissue Int; 2001 Feb; 68(2):83-6. PubMed ID: 11310351
[TBL] [Abstract][Full Text] [Related]
37. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.
Shane E; Silverberg SJ; Donovan D; Papadopoulos A; Staron RB; Addesso V; Jorgesen B; McGregor C; Schulman L
Am J Med; 1996 Sep; 101(3):262-9. PubMed ID: 8873487
[TBL] [Abstract][Full Text] [Related]
38. Bone mineral density after renal transplantation in children.
Feber J; Cochat P; Braillon P; Castelo F; Martin X; Glastre C; Chapuis F; David L; Meunier PJ
J Pediatr; 1994 Dec; 125(6 Pt 1):870-5. PubMed ID: 7996358
[TBL] [Abstract][Full Text] [Related]
39. Changes in bone mineral density and bone metabolism markers in premenopausal women with multiple sclerosis and the relationship to clinical variables.
Terzi T; Terzi M; Tander B; Cantürk F; Onar M
J Clin Neurosci; 2010 Oct; 17(10):1260-4. PubMed ID: 20619660
[TBL] [Abstract][Full Text] [Related]
40. [Vitamin D receptor gene polymorphism and the rate of bone loss of the femur neck and lumbar spine in hemodialized patients with chronic renal failure].
Karkoszka H; Chudek J; Strzelczyk P; Wiecek A; Schmidt-Gayk H; Ritz E; Kokot F
Pol Merkur Lekarski; 1998 Oct; 5(28):199-202. PubMed ID: 10101442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
